Macular degeneration, particularly age-related macular degeneration, is a leading cause of vision loss worldwide. This condition affects the central part of the retina, known as the macula, which is ...

Larry Hoffheimer watched helplessly as his mother, Florence, went from doctor to doctor seeking better glasses more than 20 years ago. Getting a diagnosis of macular degeneration didn’t resolve the ...

Wet macular degeneration is a form of age-related macular degeneration (AMD), a serious eye disease that affects the macula, the central portion of the retina that’s responsible for sharp, central ...

Nicholas G. Anderson, MD, and Philip Niles, MD, MBA, provide an overview of diabetic macular edema (DME) and the impact of vision impairment on a patient’s quality of life. Kevin U. Stephens, Sr., JD, ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

Age-related macular degeneration is the leading cause of vision loss in those who are age 50 or older. In fact, almost 20 million people in the U.S. have some type of age-related macular degeneration, ...

Current treatments sometimes fail to help people with "wet" age-related macular degeneration-- and researchers now think they know why. Wet AMD is caused by an overgrowth of blood vessels in the ...

According to the National Eye Institute, age-related macular degeneration impacts 11 million adults in the U.S. every year. Characterized by a loss of the vision needed to see straight ahead and by ...

Wet age-related macular degeneration causes abnormal blood vessels to leak fluid under the retina, damaging central vision. While there's no cure, treatments can slow progression and help preserve ...

People with a condition called wet age-related macular degeneration (AMD) often receive eye injections. These eye injections can help to improve vision and also stop the damage that causes vision to ...

The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...